ArticleJournal of biomedical optics2026
Freeform extended depth-of-focus intraocular lens for more robust performance against physiological variations.
Article in Journal of biomedical optics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Extended depth-of-focus (EDOF) intraocular lenses (IOLs) aim to provide improved visual performance over a range of distances, but their clinical outcomes are still sensitive to individual biometric variability. Improving the robustness of EDOF IOL optical performance to these patient-specific variations is critical to enhance visual predictability and patient satisfaction following cataract surgery. Aim: We aim to determine if freeform surfaces can improve the robustness of EDOF IOLs by maintaining consistent optical performance (refractive error, depth of field) despite individual biometric variations. Approach: A database of synthetic eyes was adapted to simulate pseudophakic eyes. The post-operative performances (refractive error and depth of field) for three types of EDOF IOLs (L1, L2, L3) were estimated using polychromatic Visual Strehl ratio based on the Optical Transfer Function, with photopic wavelength spectrum for a 3 mm and a 5 mm entrance pupil diameter. L1 is a standard refractive EDOF; L2 is identical to L1 but with a freeform back surface optimized in-eye; L3 is similar to L2 but calculated by a model trained to predict freeform surfaces, using preoperative biometric data (higher-order aberrations of the cornea; effective lens position, calculated from preoperative data; ELP-retina distance; and transverse position of the lens). Results: The addition of a freeform surface allowed us to significantly reduce the difference between the target refraction and subjective refraction, in polychromatic condition, for small and large pupil sizes while maintaining the depth of field. Performances with L3 were equal to L2. Conclusions: The use of a freeform surface can significantly reduce the impact of individual biometric variations such as corneal aberrations and transverse IOL positioning on EDOF behavior lenses, for small and large pupil sizes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.